Page 82 - HPP ANTIMICROBIAL GUIDELINE 2018
P. 82

INFECTIONS IN IMMUNOCOMPROMISED PATIENTS
                   A.  HAEMATOLOGY

                   1.  Any infection in the immunocompromised host is life-threatening and needs immediate attention.

                                                                                  o
                                                                                                                     o
                   2.  Febrile neutropenia is defined as a temperature of >38.3 C on a single occasion or >38 C over one hour and ANC
                          (Absolute Neutrophil Count) <500cells/uL or <1000cells/uL in those with anticipated declining counts.

                   3.  Cultures maybe positive in less than 40% of cases.

                                                                                                                                                     o
                   4.  Patients have impaired inflammatory responses and hence may have no localizing signs. The usual sign is fever>38 C or
                       hypothermia.

                   5.  The common portals of infection include the oral cavity, gastrointestinal tract, perianal region, lungs and IV lines.

                   6.  Potential pathogens are dependent on the underlying defect, e.g.

                        Neutropenia                                           Gram –ve organisms, gram +ve organisms, fungi

                        Hypogammaglobulinemia                                 Encapsulated organisms
                        Post splenectomy/ hyposplenic patients

                        Defective cellular immunity                           Pneumocystis, toxoplasma, fungi,  viruses ,
                                                                              mycobacteria

                   7.  The choice of antibiotic is based on local organisms and sensitivity patterns. The clinical state of the patient, prior infections
                       with drug resistant bacteria, recent outbreaks e.g. MRSA or multi-drug resistant Enterobacteriaceae, as well as the availability
                       and cost of the antibiotics.







               HPP AMG                                            Infections In Immunocompromised Patients                                               36
   77   78   79   80   81   82   83   84   85   86   87